In a multicenter randomized clinical trial of 440 patients with septic shock, albumin replacement therapy targeting serum levels ≥ 3.0 g/dL did not reduce 90-day mortality compared with standard ...
Long-term human albumin therapy failed to significantly improve long-term survival outcomes in cirrhotic patients with acute decompensation and ascites, the phase III randomized PRECIOSA trial showed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results